Denali Therapeutics, Inc. (DNLI)
17.54
-2.12
(-10.76%)
USD |
NASDAQ |
Dec 10, 16:00
17.54
0.00 (0.00%)
After-Hours: 18:32
Denali Therapeutics Total Assets (Quarterly): 1.056B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Masimo Corp. | 1.818B |
| Novavax, Inc. | 1.180B |
| iRhythm Technologies, Inc. | 995.21M |
| AIM ImmunoTech, Inc. | 5.494M |
| Protalix Biotherapeutics, Inc. | 82.26M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 129.42M |
| Shareholders Equity (Quarterly) | 926.20M |
| Debt to Equity Ratio | 0.0479 |
| Current Ratio | 9.791 |
| Net Debt Paydown Yield | 0.04% |